Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T12:50:39.340Z.
Calculation as of: 2026-10-06T12:50:39.340Z.
Quote observation: 2026-10-05T20:00:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 2e8745362276acfcd64f5b9abcba69827836693d7b304a16c872192b0535814a
EARNINGS YIELD
N/A
Bicara Therapeutics Inc. Common Stock
Market Cap
$1.14B
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.12B
Earnings Yield
N/A
TTM Avg
1.59%
3Y Avg
1.59%
5Y Avg
0.91%
Market Cap
$1.12B
Earnings Yield
6.66%
TTM Avg
8.81%
3Y Avg
8.09%
5Y Avg
6.50%
Market Cap
$1.16B
Earnings Yield
1.26%
TTM Avg
2.76%
3Y Avg
2.15%
5Y Avg
2.02%
Market Cap
$1.20B
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.22B
Earnings Yield
N/A
TTM Avg
1.54%
3Y Avg
1.54%
5Y Avg
1.54%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bicara Therapeutics Inc. Common Stock (BCAX) | $1.14B | N/A | N/A | N/A | N/A |
| Harrow Health, Inc. (HROW)vs › | $1.14B | N/A | 2.62% | 13.63% | 13.63% |
| Castle Biosciences, Inc. (CSTL)vs › | $1.12B | N/A | 1.59% | 1.59% | 0.91% |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.12B | 6.66% | 8.81% | 8.09% | 6.50% |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.16B | 1.26% | 2.76% | 2.15% | 2.02% |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.20B | N/A | N/A | N/A | N/A |
| Cronos Group Inc. (CRON)vs › | $1.21B | 5.57% | 3.84% | 4.37% | 4.37% |
| Teladoc Health, Inc. (TDOC)vs › | $1.05B | N/A | N/A | N/A | N/A |
| Innovage Holding Corp. (INNV)vs › | $1.22B | N/A | 1.54% | 1.54% | 1.54% |
| Immatics N.V. (IMTX)vs › | $1.04B | N/A | 3.22% | 5.54% | 5.54% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
